The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity
Advanced Science · 2024-09 · 11 (36)
DOI: 10.1002/advs.202401085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.07.2024. Verfasst von Jianan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. Hauptthemen laut MEDLINE: Glutamic Acid, Neurons, Brain Ischemia, Disease Models, Animal. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, NINDS NIH HHS, American Heart Association-American Stroke Association.
Abstract (Originalsprache)
Cytotoxic neuronal swelling and glutamate excitotoxicity are two hallmarks of ischemic stroke. However, the underlying molecular mechanisms are not well understood. Here, it is reported that SWELL1, the essential subunit of the volume‐regulated anion channel (VRAC), plays a dual role in ischemic injury by promoting neuronal swelling and glutamate excitotoxicity. SWELL1 expression is upregulated in neurons and astrocytes after experimental stroke in mice. The neuronal SWELL1 channel is activated by intracellular hypertonicity, leading to Cl − influx‐dependent cytotoxic neuronal swelling and subsequent cell death. Additionally, the SWELL1 channel in astrocytes mediates pathological glutamate release, indicated by increases in neuronal slow inward current frequency and tonic NMDAR current. Pharmacologically, targeting VRAC with a new inhibitor, an FDA‐approved drug Dicumarol, attenuated cytotoxic neuronal swelling and cell death, reduced astrocytic glutamate release, and provided significant neuroprotection in mice when administered either before or after ischemia. Therefore, these findings uncover the pleiotropic effects of the SWELL1 channel in neurons and astrocytes in the pathogenesis of ischemic stroke and provide proof of concept for therapeutically targeting it in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
- Nanozyme Medical Center, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
- Department of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, TX, 77843, USA.
- Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
- Solomon H. Snyder Department of Neuroscience, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
ORCID-Profile: Zhaozhu Qiu
Förderung
- American Heart Association
- NINDS NIH HHS
- American Heart Association-American Stroke Association
- National Natural Science Foundation of China
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Chen, J., Yang, J., Chu, J., Chen, K. H., Alt, J., Rais, R., & Qiu, Z. (2024). The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity. Advanced Science, 11(36). https://doi.org/10.1002/advs.202401085
Vancouver
Chen J, Yang J, Chu J, Chen KH, Alt J, Rais R, et al. The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity. Advanced Science. 2024;11(36). doi:10.1002/advs.202401085
BibTeX
@article{Chen2024,
author = {Chen, Jianan and Yang, Junhua and Chu, Jiachen and Chen, Kevin Hong and Alt, Jesse and Rais, Rana and Qiu, Zhaozhu},
title = {The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {36},
doi = {10.1002/advs.202401085}
}
EUVIMED